Objectives: In two studies we have compared the effects of four different saturated fat diets (medium chain fatty acids (MCFA), and lauric, myristic and palmitic acids) with those of a monounsaturated oleic acid diet on invitro whole blood aggregation in healthy women and men. Design: Study 1 had a cross-over design with three diet periods of each six weeks, and studied the effects of diets enriched in lauric, palmitic or oleic acids. Study 2 had a parallel design. After a three week oleic acid run-in diet, three groups of subjects were formed which consumed either an MCFA, myristic acid or oleic acid rich diet for six weeks. Subjects: Eighteen women and 14 men in Study 1 and 37 women and 23 men in Study 2. All subjects were healthy and were aged 20±60 y. Interventions: The experimental diets were the same in nutrient composition except for on average 8 En% (Study 1) or 10 En% (Study 2) which was provided by either MCFA, lauric acid, myristic acid, palmitic acid or oleic acid. Blood samples were taken at the end of each dietary period. Whole blood platelet aggregation, anticoagulated with recombinant hirudin was assessed after administration of collagen (®nal concentration (fc): 0.38 mg/mL) in Study 1 and collagen (fc: 0.22 mg/mL) or ADP (fc: 1.25 mmol/L) in Study 2. Collagen-induced formation of thromboxane (Tx)A 2 , measured as thromboxane (Tx)B 2 , was evaluated in Study 1 only. Results: The aggregation velocity between the saturated fatty acid diets and the monounsaturated fatty acid diet did not differ. TxB 2 concentrations measured in collagen activated blood samples, which correlated signi®cantly with aggregation velocity, did not differ between the lauric or the palmitic compared with the oleic acid diet. A stepwise regression analysis indicated that collagen-induced aggregation was negatively correlated with the number of red blood cells. ADP-induced aggregation also correlated negatively with red blood cell count, and positively with platelet count. Conclusions: The exchange of 7±10 En% from oleic acid for MCFA, lauric, myristic or palmitic acid does not affect in-vitro whole blood aggregation induced by collagen. ADP-induced aggregation is not affected when 10 En% from oleic acid is exchanged for MCFA or myristic acid. Sponsorship: This study was supported by a grant from the Dutch Dairy Foundation on Nutrition and Health.
Introduction
Blood platelets play an important role in the etiology of coronary heart disease. Activated platelets provide tissue factor, membrane phospholipid surface and other regulatory compounds, that are necessary for the coagulation process. Increased platelets reactivity for ADP was demonstrated in middle aged men at risk for coronary heart disease (Thaulow et al, 1991) and in patients with coronary heart disease . Also, the protective effect of aspirin against myocardial infarction suggests a major role of platelets in the development of coronary heart disease (Antiplatelet Trialists ' Collaboration, 1988 ; Steering Committee of the Physicians' Health Study Research Group, 1989) , as it inhibits platelet synthesis of thromboxane A 2 (TxA 2 ). Different types of dietary fatty acids have been demonstrated to change the reactivity of platelets. Renaud and coworkers (1986) found decreased thrombin-induced and increased ADP-induced platelet rich plasma (PRP) aggregation when farmers switched from high saturated fat diets to high polyunsaturated fat diets for one year. Mutanen and coworkers (1992) demonstrated lower ADP-and collageninduced PRP aggregation on a dairy fat diet compared with diets rich in unsaturated fatty acids from rapeseed or sun¯ower oil. Ng et al (1992) , in addition, found increased thromboxane B 2 (TxB 2 ) in collagen-activated whole blood comparing diets rich in coconut with palm oil. This observation (Ng et al, 1992) suggested that the various saturated fatty acids have different effects on platelet activity and that thromboxane dependent aggregation increases with diets rich in fatty acids from coconut oil (for example, MCFA, lauric and myristic acid). However, effects of speci®c saturated fatty acids on platelet aggregation have hardly been investigated systematically.
Platelet aggregation is frequently measured with the optical density technique using citrated PRP and activators of aggregation such as ADP, collagen or thrombin. This technique might not always be preferable, since it does not take into account the possible role of short-lived plasmatic components and of red and white blood cells. In this present study, therefore, the effects of diets enriched in MCFA, lauric, myristic and palmitic acid on aggregation in whole blood in vitro were investigated and compared with those of oleic acid.
Methods

Design and statistical analysis
The project consisted of two separate studies also designed to investigate the effects of separate saturated fatty acids on lipoproteins, coagulation and ®brinolysis as reported elsewhere (Temme et al, 1996 (Temme et al, , 1997b . The protocols of both studies had been approved by the ethical committee of Maastricht University. All subjects had given their written informed consent.
In the ®rst study (Study 1) the effects of lauric acid, palmitic acid and oleic acid were investigated using a cross-over study design. The three different diets were consumed by 32 healthy subjects, 18 women and 14 men, for six weeks separated with wash out periods from two or three weeks. The second study (Study 2) examined the effects of MCFA and myristic acid versus oleic acid with a parallel study design. After a run-in period of three weeks, in which 60 volunteers, 37 women and 23 men, consumed an oleic acid diet, the subjects were divided into three groups; the ®rst group received an MCFA diet (n 21), the second group a myristic acid diet (n 20) and the last group continued with the oleic acid diet (n 19).
Data were analysed using the General Linear Models (GLM) procedure of the Statistical Analyses System. In Study 1, the aggregation parameters at the end of each dietary period were analysed with diet, period and diet-andsex interaction as independent variables. Data of TxB 2 were logarithmic transformed before analysis, because they were not normally distributed. In Study 2, changes in aggregation parameters from the end of the run-in to the end of the experimental period were analysed with diet, sex and dietand-sex interaction as independent variables. Pearson correlation coef®cients were calculated between aggregation velocity and hematological parameters. Correlations were calculated when subjects consumed the oleic acid diet during the experimental period (Study 1) or the run-in period (Study 2). To determine the relationship between hematological parameters and aggregation in whole blood, a stepwise regression procedure (forward selection) was performed with whole blood aggregation velocity as dependent and the main hematological parametersÐplatelet count, red blood cell count and white blood cell countÐ as independent variables. The signi®cance level for entry in the model was set at 0.05.
In both studies differences in responses between women and men were evaluated with unpaired t-tests. ). Nine women were postmenopausal and 10 women used oral contraceptives, six women and ®ve men smoked.
Diets
The diets of both studies consisted of products in which the normal fat was replaced by experimental fats. Total fat energy was on average 40% of energy (En%). The experimental fats supplied 70% of the total fat energy in the ®rst and 63% in the second study. The nutrient composition of the calculated diets was similar except that approximately 8 En% (Study 1) or 10 En% (Study 2) of oleic acid was exchanged for lauric acid or palmitic acid (Study 1) and for MCFA or myristic acid (Study 2). These differences were achieved by the use of special experimental fats. The lauric acid fat was a mixture of palm kernel (75%) (Wesco; Karlshamns, Zaandijk, the Netherlands) and a high oleic acid sun¯ower oil (25%) (Trisun; SVO enterprises, Wickliffe, USA). The palmitic acid fat consisted of dairy fat (55%) (FDF, Leeuwarden, The Netherlands), palmstearin (36%) (Aarhus oil, Aarhus, Denmark) and sun¯ower oil (9%) and the fat high in oleic acid of dairy fat (37%) and high oleic acid sun¯ower oil (63%). Cholesterol was added to the fats high in lauric and oleic acid, so that all fats contained 145 mg of cholesterol per 100 g of fat. The fat high in MCFA was made by interesteri®cation of 34.0% palm stearin, 17.6% high oleic acid sun¯ower oil, 8.4% sun¯ower oil, and 40% medium chain triglyceride (MCT) oil. The composition of the MCT oil was 33.3% C6:0, 25.3% C8:0, and 41.5% C10:0. The myristic acid fat was made by interesteri®cation of a blend of 34% palm stearin, 17% high oleic acid sun¯ower oil, 9% sun¯ower oil and 40% trimyristin. The oleic acid fat consisted of a blend of 30% palm stearin and 70% high oleic sun¯ower oil (Gru Ènau GMBH, Illertissen, Germany). Margarines were made from the fats and consisted of 83% fat and 17% water. The experimental margarines were given as such and were incorporated in bread, biscuits, pies, cakes (Study 1 and Study 2), cheeses and custards (Study 1 only).
The study diets were formulated at different levels of energy, so that each subject received a diet that met his or her energy needs. According to these energy levels lists were computed which stated the amount of experimental products the subject had to eat each day or each week. Products were handed out on an individual basis and were free of charge. 30% (Study 1) and 37% (Study 2) of the total fat intake was free of choice. The subject could choose these`free' products from a list of fat containing products. Subjects came at least once a week to a special room in the University to get a new supply of products and to be weighted. They were also asked to maintain the same activity level, smoking and drinking habits throughout the study. Any changes were written down in a special diary as well as medication used, illnesses, daily alcohol use and menstrual cycle.
Blood sampling and measurements
Blood was sampled after an overnight fast and after abstinence from drinking the preceding day and smoking on the morning before blood sampling. Blood for platelet Saturated fatty acids and platelet aggregation EHM Temme et al aggregation was sampled at the end (week 6) of each period in Study 1 and at the end of the run-in (week 3) and the end of the experimental period (week 9) in Study 2. Blood was sampled with a minimum of stasis and using a 1.2 mm needle (Strauû Kanule, Luer, Wa Èchtersbach, Germany) with the subject in recumbent position. All venipunctures were performed by the same person, at the same location, and for each subject generally at the same time of the same day of the week. The ®rst 3±4 mL blood was collected in an EDTA tube to count the number of platelets (Hematology system, Technicon Instruments Corporation, Tarrytown, NY, USA) in Study 1 and to measure complete hematological parameters in Study 2 (Coulter microdiff 18, Coulter Corporation, Miami, FL, USA). Then, 1.5 mL of blood was collected in a tube containing 67 mg/mL recombinant desulphatohirudin variant 1 ( TM Revasc; a gift from Novartis Pharma AG, Horsham, Great Britain). Whole blood aggregation was immediately measured after blood sampling using a whole blood aggregometer (Chrono-log whole blood aggro-meters, model 500 (Study 1 and Study 2) and model 540 (Study 2)) (Chrono-log Corporation, Haverton, PA, USA). 1 mL of blood was transferred to a pre-warmed plastic cuvet and the electrodes were inserted in the cuvettes. The sample was stirred at 1000 rpm, kept at 37 C and allowed to reach equilibrium. After calibrating the instrument, 10 mL of the aggregation inducer (collagen or ADP) was added. Aggregation curves were registered for 15 min and the velocity was expressed as the steepest slope of the aggregation curve (O/min). When aggregation curves of ADP-induced aggregation consisted of two curves the steepest slope of the ®rst curve was determined.
In Study 1, platelet aggregation was induced by addition of collagen (Collagen Horm, Hormon Chemie, Munich, Germany) at a ®nal concentration of 0.38 mg/mL. In Study 2, collagen-and ADP-(Sigma Chemical Co, St Louis, MO, USA) induced aggregation were measured. Final concentrations were 0.22 mg/mL for collagen and 1.25 mmol/L for ADP. Samples of the subjects were measured at the same channel of the aggregometer along the study. Due to an occasional technical problem with the aggregometers, aggregation values of some subjects are missing, which has been emphasized in the tables.
After 15 min of activation, collagen-activated aggregation samples from Study 1 were centrifuged in an eppendorf centrifuge for 3 min, to measure TxB 2 production. The plasma samples were then immediately snap-frozen and stored at 7 80 C. The TxB 2 concentration was determined with an Enzyme Immunoassay (Cayman Chemical Company, Ann Harbor, MI, USA). Coef®cient of variation within runs was 6.1%. All samples from the same subject were analysed within one assay run.
Results
Dietary composition
The mean daily energy intake and the composition of the diets was determined from four days food records in Study 1 and three days food records in Study 2. In addition, duplicate portions of food and drinks consumed have been collected by the subjects for two days (Study 1). Lipids of these portions were extracted and fatty acid composition determined.
In Study 1, total fat intake was 41.5 En% with the lauric acid diet, 41.0 En% with the palmitic acid diet and 41.8 En% with the oleic acid diet. As determined from the duplicate portions, the difference in lauric acid was 7.3 En% between the lauric and the oleic acid diet, while the palmitic acid diet was 6.1 En% higher in palmitic than the oleic acid diet. The lauric acid diet contained also some (average 1.8 En%) more myristic acid than the other two diets. The diets did not differ with respect to linoleic acid or a-linolenic acid intakes (Temme et al, 1997a) .
In Study 2, the average intake of fat was 39 En%. The average intake of oleic acid was 15.1 En% during the run-in period and decreased in the test period to 6.6 En% with the MCFA and to 6.3 En% with the myristic acid diet. It was exchanged for extra MCFA or myristic acid. Oleic acid intake during the oleic acid diet did not change from the run-in to the test period. Changes of other nutrients, except for En% saturated and monounsaturated fatty acids, did not signi®cantly differ between the diets.
Relative to the oleic acid diet, fatty acid composition of pooled serum samples in both studies (Temme et al, 1997a (Temme et al, , 1997b did not indicate signi®cant changes in the proportions of linoleic acid, a-linolenic acid, arachidonic acid or total polyunsaturated fatty acids. Table 1 shows that collagen-induced aggregation velocity and TxB 2 production after six weeks consumption of diets enriched in lauric, palmitic or oleic acids did not differ signi®cantly between the diets. Also, diets rich in MCFA and myristic acid (Study 2) did not affect collagen-and ADP-induced aggregation velocity differently as compared with a diet rich in oleic acid (Table 2) .
Platelet aggregation and TxB 2
In Study 1, logarithmic transformed values of TxB 2 concentrations correlated with aggregation velocity (r 0.42 (P 0.0165), r 0.48 (P 0.0055), r 0.39 (P 0.0274), for subjects on the lauric, palmitic or oleic acid diet, respectively).
In Study 2, collagen-induced aggregation velocity was slightly higher in subjects that smoked compared with the nonsmokers (5.31 AE 2.93 O/min in smokers versus 5.05 AE 1.72 O/min in nonsmokers; P 0.0221), but did not differ between them in Study 1. Also, ADP-induced aggregation in Study 2 did not signi®cantly differ between smokers and non-smokers. Collagen-induced aggregation Collagen-and ADP-induced aggregation velocities after the run-in period in Study 2, however, were signi®cantly higher in women compared with men (P 0.0020 and P 0.0010, respectively). The data of collagen-induced aggregation velocity of the females consuming the oleic acid diet (oleic acid diet period in Study 1 and oleic acid run-in period in Study 2) were combined to determine differences between pre-and postmenopausal women. Collagen-induced aggregation velocity was (means AE standard deviation) 5.2 AE 1.8 O/min in premenopausal women not on contraceptives (n 27, one missing value), 6.6 AE 1.4 O/min in premenopausal women on contraceptives (n 11, one missing value) and 5.9 AE 2.2 O/min in postmenopausal women (n 15) and did not differ signi®-cantly between these groups of women. ADP-induced aggregation velocity, which was only measured in Study 2, was 6.6 AE 1.9 O/min in premenopausal women not on contraceptives (n 17, one missing value), 5.6 AE 1.2 O/min in premenopausal women on contraceptives (n 10) and 5.7 AE 1.1 O/min in postmenopausal women (n 9) and did not differ in a signi®cant different way between these women.
Hematologic parameters
Platelet count in Study 1 did not change throughout the study and did not differ between women and men (data not shown). Platelet counts correlated signi®cantly with platelet aggregation velocity (r 0.40 (P 0.0217), r 0.47 (P 0.0069), r 0.48 (P 0.0049), on the lauric, palmitic or oleic acid diet, respectively). In Study 2 more hematologic parameters were measured (Table 3) . Although changes did not differ signi®cantly between the three diets, a trend was observed for a decreased mean platelet volume with the myristic acid (mean response of 7 0.2 fL; P 0.0006) compared with the MCFA diet (difference of changes 7 0.3 fL; P 0.0659, 95% Con®dence Interval 7 0.7±0.1 fL). After the run-in period in Study 2, red blood cell concentrations were higher in men than in women (4.9 AE 0.3 6 10 12 /L vs 4.4 AE 0.3 6 10 12 /L; P`0.0001). Other red blood cell related parametersÐhemoglobin and hematocritÐwere also higher in men compared with women, whereas platelet count and mean platelet volume did not differ between the two sexes (see Table 3 ). Whereas collagen-induced aggregation was not correlated with platelet count (r 0.20, P 0.1368), ADP-induced aggregation velocity was (r 0.39, P 0.0026). Both collagenand ADP-induced aggregation velocity were inversely correlated with the concentration of red blood cells (r 7 0.38, P 0.0035 for collagen-induced aggregation, r 7 0.48, P`0.0001 for ADP-induced aggregation).
Independent hematologic determinants of whole blood platelet aggregation velocity as measured after the run-in period in Study 2 were evaluated with a stepwise forward regression analysis and are shown in Table 4 . The red blood cell count was negatively related to collagen-and ADPinduced aggregations. ADP-induced aggregation was also, but to a lesser extent, positively associated with platelet count.
Discussion
Compared with monounsaturated fatty acids (oleic acid), diets enriched in saturated fatty acids (MCFA, lauric acid, myristic acid or palmitic acid) did not change aggregation velocity in vitro in whole blood samples anticoagulated with hirudin. From measurements in PRP, Mutanen et al (1992) reported lower ADP-and collagen-induced aggregations after consumption of diets rich in dairy fat compared with diets rich in rapeseed oil (oleic acid and alinolenic acid) or sun¯ower oil (linoleic acid). It was suggested (Mutanen et al, 1992 ) that these effects were due to differences in the linoleic acid and a-linolenic acid ratio of the diets and not to the exchange of saturated for unsaturated fatty acids. In our study, the diets given did not differ with respect to linoleic acid (Study 1 and 2) or alinolenic acid (Study 1) content as determined from the recorded food intakes (Study 2) or the duplicate portions (Study 1) (Temme et al, 1997a) . Therefore, the present study does not necessarily contradict this suggestion (Mutanen et al, 1992) , but can also not con®rm because collagenand ADP-induced aggregation have now been measured in whole blood samples. Earlier, Renaud and co-workers (1986) also reported increased ADP-induced aggregation when farmers replaced their saturated fat diets for one year, with diets rich in linoleic acid. For the next three years, when they increased the intake of oleic and a-linolenic acid at the expense of linoleic acid, ADP-induced PRP aggregation was similar to levels on the saturated fat diet. Both replacements, however, reduced collagen-and thrombininduced aggregation compared with the saturated fat diet. Therefore, it remains uncertain whether this ratio of dietary linoleic acid and a-linolenic acid might also be important for aggregations induced with other stimuli than ADP. One of the mechanisms to alter platelet aggregation is via the production of TxA 2 , which is synthesized by platelets and promotes platelet aggregation, and of PGI 2 , which is produced by endothelial cells and inhibits platelet aggregation. Both eicosanoids are derived from arachidonic acid, an important fatty acid of membrane phospholipids, the concentrations of which can be altered by changes in dietary fatty acid composition. Our results did not indicate changes in the TxB 2 concentrations (a TxA 2 -metabolite) after diets rich in lauric or palmitic acids compared with oleic acid, in collagen activated samples. Others, however, showed that diets rich in coconut oil (lauric and myristic acids) compared with palm oil (palmitic acid) or olive oil (oleic acid) increased the concentrations of TxB 2 , in collagen activated whole blood samples, whereas the concentration of 6-ketoPGF 1a (a PGI 2 -metabolite) decreased compared with palm oil (Ng et al, 1992) . The experimental periods in our and their (Ng et al, 1992 ) study were of the same duration. The exchange of lauric acid for palmitic acid in our study, however, was smaller (7 En% instead of 12 En% exchanged), which might have in¯uenced the results. Aggregation was not measured in that study (Ng et al, 1992) .
Our results seem in agreement with those of Mustad et al (1993) , who did not indicate an altered excretion of eicosanoid metabolites (TxB 2 and 6-ketoPGF 1a ) in urine after 26 d consumption of diets enriched in butter fat compared with cocoa butter or milk chocolate (4 En% lauric plus myristic acid was exchanged for stearic acid). This lack of changes was observed despite an increase in the proportion of arachidonic acid in platelet phospholipid membranes with the butter fat compared with the cocoa butter diet (Mustad et al, 1993) . Whether urinary TxB 2 really re¯ects platelet thromboxane biosynthesis, however, has been disputed (Catella et al, 1986) .
The components of blood that in¯uenced whole blood aggregation most were red blood cell counts and platelet counts, the latter for ADP-induced aggregation only. The observed inverse association between red blood cell count and whole blood aggregation was also present in the study that demonstrated a marked association between ADPinduced whole blood aggregation and prevalent ischemic heart disease ) and a cross sectional study in elderly subjects (Emery et al, 1995) . However, for collagen-induced whole blood aggregation, this association was not observed (Emery et al, Saturated fatty acids and platelet aggregation EHM Temme et al 1995) . This inverse association might explain the sex differences in ADP-induced aggregation velocity, as women have lower red blood cell counts than men. Why the gender differences were less pronounced with the collagen-induced aggregation is not clear, as also for collagen-induced aggregation an inhibitory effect of red blood cells was demonstrated.
Conclusions
The combined action of the blood components on in-vitro whole blood aggregation induced by collagen, however, was not affected by the exchange of 7±10 En% from oleic acid for MCFA, lauric, myristic or palmitic acid. Also, a 10 En% exchange from oleic for MCFA or myristic acid did not affect ADP-induced aggregation.
